BIO-TECHNE ANNOUNCES PUBLICATION OF NEW DATA DEMONSTRATING EXODX PROSTATE TEST CORRELATION WITH POST-PROSTATECTOMY PATHOLOGY OUTCOMES
- Monday, February 14, 2022, 7:17
- PR Newswire
- Add a comment
MINNEAPOLIS, Feb. 14, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced an important publication in World Journal of Urology, entitled Pre–diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post–prostatectomy pathology outcome. Principal investigator…
About the Author
admin has written 20655 stories on this site.